In their mid-year review of M&A and private equity activity, several league tables ranked Pillsbury’s Corporate practice among the Top 20 legal advisers in the U.S. and Japan.

Significantly, Factset identified Pillsbury as the 14th most active firm in Japan for M&A deals and 17th for U.S. middle-market M&A transactions. Similarly, Refinitiv listed Pillsbury as 20th for deal count among firms handling U.S. middle-market mergers and acquisitions in the first half of the year.

In its H1 2019 league tables, Bloomberg recognized Pillsbury as the 18th most active law firm advising on middle-market deals valued up to $250 million and 19th for global private equity transactions valued up to $50 million by deal value.

Some of the firm’s 2019 transactional highlights in the first half of the year include representing Invitae Corp. in its acquisition of artificial intelligence-driven biotechnology company Jungla; advising clinical-stage cancer treatment developer Salarius Pharmaceuticals LLC on its pending merger with Flex Pharma Inc.; representing Barefoot Networks in its acquisition by Intel; advising Delta Electronics on its $90 million acquisition of Amerlux; and guiding WestJet in its $3.7 billion deal with Onex.

Pillsbury is among the world’s foremost legal advisors for mergers and acquisitions of all sizes and in markets around the world. Leveraging the experience and insight of more than 100 M&A lawyers globally, the firm offers clients the strategic guidance and innovative solutions necessary to successfully close in even the most challenging transactions.